CRP and cancer: Specifically, performing high-intensity concurrent resistance and aerobic training during cancer treatment results in a lesser increase of the plasma inflammatory markers CRP and TNF-α immediately after completion of cancer treatment, compared to performing low-intensity concurrent resistance and aerobic training [98].